Cosmetic Ingredient Use Under Feinstein Bill; Where Does CIR Come In?

Whereas previous industry-backed legislation would have made final Cosmetic Ingredient Review safety determinations de facto FDA requirements unless the agency concluded differently, CIR would play a less conspicuous role in national cosmetics oversight under the proposed Personal Care Products Safety Act. Meanwhile, manufacturers would be required to file ingredient statements with FDA and attest to product safety, with opportunities for FDA to rebut their assertions and even suspend their distribution activities.